![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 44, 31127-31130, October 29, 1999
From the Departments of The ATM gene is mutated in
individuals with ataxia telangiectasia, a human genetic disease
characterized by extreme sensitivity to radiation. The ATM protein acts
as a sensor of radiation-induced cellular damage and contributes to
cell cycle regulation, signal transduction, and DNA repair; however,
the mechanisms underlying these functions of ATM remain largely
unknown. Binding and immunoprecipitation assays have now shown that ATM
interacts with the histone deacetylase HDAC1 both in vitro and in
vivo, and that the extent of this association is increased after
exposure of MRC5CV1 human fibroblasts to ionizing radiation. Histone
deacetylase activity was also detected in immunoprecipitates prepared
from these cells with antibodies to ATM, and this activity was blocked
by the histone deacetylase inhibitor trichostatin A. These results
suggest a previously unanticipated role for ATM in the modification of
chromatin components in response to ionizing radiation.
The human genetic disease ataxia telangiectasia
(AT),1 which is characterized
by extreme sensitivity to radiation, is caused by mutations in the
ATM gene (1, 2). The protein encoded by this gene acts as a
sensor of radiation-induced cellular damage and plays important roles
in cell cycle regulation, signal transduction, and DNA repair (2-6).
However, the mechanisms by which ATM performs these various functions
remain largely uncharacterized.
Exposure of cells to ionizing radiation results in the arrest of cell
cycle progression, induction of the transcription of specific genes,
modification of nucleosomal structure, and activation of the DNA repair
machinery (3, 6). Histone acetylation and deacetylation are thought to
play important roles in the modification of chromatin structure and in
monitoring chromosomal integrity during the cell cycle and
transcriptional regulation (7-9). Various non-histone proteins that
participate in regulation of the cell cycle and transcription are
associated with histone acetylation or deacetylation activities
(10-14). Certain transcriptional coactivators, including pCAF, BRCA2,
and ATM-like proteins, possess intrinsic acetylation activities
(15-18). Conversely, transcriptional repressors have been shown to
associate with histone deacetylases (19-24). Recent studies have shown
that the product of the retinoblastoma gene (Rb) represses
transcription of the E2F gene by recruiting the mammalian
deacetylase proteins HDAC1 and HDAC2, to which it binds through an
LXCXE motif in its pocket domain (24-27).
Sequence analysis has revealed that the NH2 terminus of ATM
contains an LXCXE motif (amino acids 115-119)
(Fig. 1a). We therefore investigated whether ATM also
interacts with HDAC1. We have now shown that the two proteins indeed
interact both in vitro and in vivo and that the
extent of the association in vivo is increased by exposure
of the cells to ionizing radiation.
Cell Culture and Irradiation--
Human normal (MRC5CV1) and AT
(AT5BIVA, AT4BIVA, and AT3BIVA) fibroblasts were maintained at 37 °C
under an atmosphere of 5% CO2 in Eagle's minimum
essential medium supplemented with 10% fetal bovine serum.
Exponentially growing cells were exposed to 20 Gy of GST-ATM Constructs--
An expression vector encoding a
glutathione S-transferase (GST) fusion protein containing residues
1-300 of ATM (GST-ATM(1-300)) was generated by inserting the
corresponding polymerase chain reaction-generated
BamHI-EcoRI fragment of human ATM cDNA (2) into pGEX-4T-1 (Kodak). A cDNA encoding a mutant fusion protein (GST-ATM(C117F)) in which Cys117 of the
LXCXE motif of ATM was replaced by phenylalanine
was generated from GST-ATM(1-300) cDNA with the use of a
QuickChange site-directed mutagenesis kit (Stratagene). An expression
vector encoding a GST-I In Vitro Translation and GST Precipitation Assays--
The
1.4-kb full-length human HDAC1 cDNA, a gift from Dr. Schreiber
(28), incorporated into the pcDNA3 vector (Invitrogen) was
subjected to in vitro transcription and translation in the presence of [35S]methionine with a TNT T7-coupled
transcription and translation kit (Promega). Beads coated with GST
fusion proteins (10 µg) were incubated for 1 h at 4 °C with
in vitro translated 35S-labeled HDAC1 (10 µg)
or nuclear extracts (1 mg of protein) in a final volume of 400 µl
containing TNN buffer (40 mM Tris-HCl (pH 8.0), 120 mM NaCl, 0.5% (v/v) Nonidet P-40, and protease inhibitors) (5). After extensive washing of the beads, bound proteins were analyzed
by SDS-polyacrylamide gel electrophoresis and either autoradiography or
immunoblot analysis with antibodies to HDAC1 (Santa Cruz Biotechnology).
Immunoprecipitation and Immunoblot Analysis--
Nuclear
extracts were prepared as described (5), and the concentration of
protein was determined with the Bradford reagent (Bio-Rad). The
extracts (1 mg of protein) were subjected to immunoprecipitation for
2 h at 4 °C with antibodies to HDAC1 in a final volume of 20 µl of TNN buffer. After the addition of protein A/G-agarose (Santa
Cruz Biotechnology), the reaction mixtures were incubated for an
additional 2 h. The immunoprecipitates were washed extensively and
subjected to SDS-polyacrylamide gel electrophoresis, and the separated
proteins were then transferred to a nitrocellulose membrane (Schleicher
& Schuell) and subjected to immunoblot analysis as described (5).
Histone Deacetylase
Assay--
[3H]Acetyllysine-labeled histones were
isolated from HeLa cells as described (29, 30). Nuclear extracts (1 mg
of protein) were incubated for 2 h at 37 °C with the labeled
histones (12,000 cpm) in a final volume of 100 µl containing HDAC
buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl,
10% (v/v) glycerol, 0.5% (v/v) Triton X-100). The reaction was then
terminated, and released acetate was assayed. Assays were also
performed with precipitates of nuclear extracts prepared with either
GST fusion protein-coated beads or antibodies to ATM (Calbiochem); the
beads and immunoprecipitates were washed extensively with buffer A (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM MgCl2, 1 mM CaCl2,
0.4% Nonidet P-40) before the assay. All samples were assayed in duplicate.
To investigate whether ATM interacts with HDAC1, we performed
in vitro protein-protein binding assays. In vitro
translated 35S-labeled HDAC1 was incubated with beads
coated with a bacterially produced GST fusion protein containing
residues 1-300 of ATM. Beads coated with GST or with a GST fusion
protein containing the NF- We next determined whether the interaction between ATM and HDAC1
contributes to the cellular response to ionizing radiation-induced DNA
damage. Normal human fibroblasts (MRC5CV1) were exposed to 20 Gy of
COMMUNICATION
Sensing of Ionizing Radiation-induced DNA Damage by ATM
through Interaction with Histone Deacetylase*
,
,
,
,
, and
§¶
Radiation Medicine and
§ Microbiology, Division of Radiation Research, Vincent
T. Lombardi Cancer Center, Georgetown University Medical Center,
Washington, D. C. 20007
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-radiation
(J. L. Shepherd Mark I Radiator) with a 137Cs source
emitting at a fixed dose rate of 3.83 Gy min
1 and were
harvested at various intervals thereafter.
B
fusion protein was prepared as described
(4). All fusion proteins were produced in and purified from
Escherichia coli also as described (4).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
B inhibitor protein I
B
were used as
controls. The 35S-labeled HDAC1 bound to the beads coated
with GST-ATM(1-300) but not to those coated with GST or GST-I
B
(Fig. 1b). To assess further
the specificity of this interaction, we generated the mutant protein
GST-ATM(C117F), in which Cys117 of the
LXCXE motif of ATM was replaced by phenylalanine
with the use of site-directed mutagenesis (24). The extent of the interaction of GST-ATM(C117F) with HDAC1 was greatly reduced relative to that observed with GST-ATM(1-300). The electrophoretic mobilities of the wild-type and mutant GST-ATM proteins differed slightly, possibly because of a conformational change induced by the mutation. Together, these data suggest that the LXCXE motif
of ATM is required for binding of the protein to HDAC1.

View larger version (18K):
[in a new window]
Fig. 1.
Role of the
LXCXE motif of ATM in its interaction
with HDAC1. a, schematic representation of the domain
organization of ATM. The locations of the LXCXE
motif and of the leucine zipper (LZ), proline-rich
(PR), and phosphatidylinositol 3-kinase (PI3K)
domains in the ATM protein are indicated. The sequences of the
LXCXE motifs of human Rb, human ATM, and human
HDAC1 are also compared; dashes in the HDAC1 sequence
represent gaps introduced to optimize alignment. b, in
vitro assay of the interaction between ATM and HDAC1. In
vitro translated 35S-labeled HDAC1 was incubated with
beads coated with GST, GST-ATM(1-300), GST-ATM(C117F), or
GST-I
B
. The beads were then washed, after which bound proteins
were detected by SDS-polyacrylamide gel electrophoresis and
autoradiography (upper panel). A portion (2%) of the
35S-HDAC1 added to each binding mixture was analyzed for
comparison. The various GST substrates were also visualized by
Coomassie Blue staining of the gel (lower panel).
-radiation, and after various intervals, nuclear extracts were
prepared and subjected to the in vitro binding assay with beads coated with GST-ATM(1-300). Immunoblot analysis with antibodies to HDAC1 of proteins that bound to the beads revealed that HDAC1 present in the nuclear extracts bound to GST-ATM(1-300) (Fig. 2a). The amount of HDAC1 bound
to GST-ATM(1-300) was maximal 30 min after irradiation and then
gradually decreased to basal levels over the next ~3 h. HDAC1 in
nuclear extracts did not bind to beads coated with GST alone (data not
shown). Immunoprecipitates prepared from the nuclear extracts with
antibodies to HDAC1 also contained ATM (Fig. 2b). The amount
of ATM present in the immunoprecipitates was maximal between 30 and 60 min after irradiation and had returned to basal levels by 3 h. The
amount of HDAC1 in the immunoprecipitates was not substantially
affected by ionizing radiation. The interaction between ATM and HDAC1
was not detected by immunoprecipitation analysis in AT5BIVA (Fig.
2c) or in AT3BIVA or AT4BIVA (data not shown) cell lines,
all of which are derived from AT patients; these cells express HDAC1 at
levels similar to MRC5CV1 cells (Fig. 2d).
Immunoprecipitates obtained from MRC5CV1 cells with antibodies to IgG
as a control did not contain ATM (data not shown). These results
demonstrate that ATM associates with HDAC1 in vivo and that
the extent of this association is increased by exposure of cells to
ionizing radiation.

View larger version (25K):
[in a new window]
Fig. 2.
Ionizing radiation-induced interaction of
HDAC1 with ATM in vivo. a, MRC5CV1
cells were exposed to ionizing radiation (20 Gy), and at the indicated
times thereafter, nuclear extracts were prepared and incubated with
beads coated with GST-ATM(1-300). Proteins that bound to the beads
were subjected to SDS-polyacrylamide gel electrophoresis on a 7% gel
and immunoblot analysis (IB) with antibodies to HDAC1. A
portion of the nuclear extract from nonirradiated cells corresponding
to 25% of the input to the binding reaction mixture was also directly
subjected to immunoblot analysis (lane NE). b and
c, nuclear extracts were prepared from MRC5CV1 and AT5BIVA
cells, respectively, at the indicated times after irradiation and
subjected to immunoprecipitation (IP) with antibodies to
HDAC1. The resulting immunoprecipitates, as well as a portion of the
nuclear extract of nonirradiated cells corresponding to 10% of the
input for immunoprecipitation, were then subjected to immunoblot
analysis with antibodies to ATM or to HDAC1 as indicated. d,
nuclear extracts (20 µg of protein) prepared from MRC5CV1 cells and
the indicated AT cell lines were subjected to immunoblot analysis with
antibodies to HDAC1.
The ATM-like proteins pAF400, Tra1, and TRRAP associate with histone
acetylase protein complexes (14, 17, 18). In contrast, we have observed
that ATM interacts with HDAC1 but not with pCAF (data not shown). To
investigate the effect of ionizing radiation on histone acetylase and
deacetylase activities, we first monitored the amount of acetylated
histone H4, by immunoblot analysis of acid-soluble proteins after
irradiation of MRC5CV1 cells. The abundance of acetylated histone H4
was reduced by 80 and 91% at 30 and 60 min after irradiation before
recovering to 47% of pretreatment levels at 3 h (Fig.
3a). Equal loading was
confirmed by Ponceau staining of the membrane (data not shown). In
contrast, the amount of acetylated histone H4 was markedly increased by
treating cells with the histone deacetylase inhibitor trichostatin A
(TSA). We also measured the effect of ionizing radiation on histone
deacetylase activity in both MRC5CV1 and AT cells. The amount of
deacetylase activity in MRC5CV1 cells was increased within 30 min of
irradiation and thereafter gradually decreased to basal levels by
3 h after treatment (Fig. 3b). The deacetylase activity
of AT5BIVA cells was not affected by ionizing radiation. Thus, the
radiation-induced decrease in the amount of acetylated histone H4
correlated with the increase in deacetylase activity in MRC5CV1
cells.
|
To determine whether the HDAC1 associated with ATM exhibits histone
deacetylase activity, we incubated nuclear extracts of MRC5CV1 cells
with beads coated with GST-ATM(1-300) and then assayed the
bead-associated proteins for deacetylase activity. Such beads showed a
high level of deacetylase activity, which was inhibited by treatment
with TSA (Fig. 4a). Beads
coated with GST, GST-I
B
, or GST-ATM(C117F) retained much less
histone deacetylase activity after incubation with MRC5CV1 nuclear
extracts than did GST-ATM(1-300)-coated beads. Furthermore, the amount
of ATM-associated histone deacetylase activity was increased 30 min
after exposure of MRC5CV1 cells to ionizing radiation, as revealed by
GST-ATM(1-300) precipitation and immunoprecipitation assays (Fig.
4b); immunoprecipitates prepared with an irrelevant antibody
did not exhibit histone deacetylase activity (data not shown).
|
Taken together, our data indicate that ATM associates with HDAC1
in vivo, that the resulting complex exhibits histone
deacetylase activity, and that the extent of this association is
increased in cells exposed to ionizing radiation. Although whether the
mechanism by which ATM affects the acetylation state of the histone is
related to chromatin is the subject of further investigations, the
present results reveal a new role for ATM in the cellular response to ionizing radiation-induced DNA damage. Our data with AT cells indicate
that mutations in the ATM gene affect the interaction between ATM and HDAC1 and thereby prevent the increase in histone deactylase activity apparent in normal cells after exposure to ionizing
radiation. This observation is consistent with previous studies (6, 31,
32) showing that ATM is associated with chromatin and that
decondensation of chromatin increases the radiosensitivity of DNA with
respect to formation of double-strand breaks. Therefore, it is also
possible that AT cells show an increased susceptibility to
radiation-induced DNA damage because of the dysfunction of ATM as a
regulator of DNA packaging into chromatin and a monitor of chromosomal integrity.
| |
ACKNOWLEDGEMENTS |
|---|
We thank M. Smulson and H. Kwon for critical comments and discussions, as well as J. Tuturea and E. North for technical support and manuscript preparation, respectively. We also thank Drs. S. L. Schreiber and H. Kwon for providing pHDAC1.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grant PO1 CA 74175.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Radiation Medicine, Div. of Radiation Research, Georgetown University Medical Center, The Research Bldg., Rm. E211A, 3970 Reservoir Rd. N. W., Washington, D. C. 20007. Tel.: 202-687-8352; Fax: 202-687-0400; E-mail: jungm@gunet.georgetown.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: AT, ataxia telangiectasia; ATM, the gene mutated in AT patients; GST, glutathione S-transferase; TSA, trichostatin A.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Savitsky, K.,
Bar-Shira, A.,
Gilad, S.,
Rotman, G.,
Ziv, Y.,
Vanagaite, L.,
Simmons, A.,
Clines, G. A.,
Sartiel, A.,
Gatti, R. A.,
Chessa, L.,
Sanal, O.,
Lavin, M. F.,
Jaspers, N. G. J.,
Taylor, A. M. R.,
Arlett, C. F.,
Miki, T.,
Weissman, S.,
Lovett, M.,
Clines, F. S.,
and Shiloh, Y.
(1995)
Science
268,
1749-1753 |
| 2. |
Savitsky, K.,
Sfez, S.,
Tagle, D. A.,
Ziv, Y.,
Sartiel, A.,
Collins, F. S.,
Shiloh, Y.,
and Rotman, G.
(1995)
Hum. Mol. Genet.
4,
2025-2032 |
| 3. | Gottlieb, T. M., and Jackson, S. P. (1993) Cell 72, 131-142[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Jung, M.,
Kondratyev, A.,
Lee, S. A.,
Dimtchev, A.,
and Dritschilo, A.
(1997)
Cancer Res.
57,
24-27 |
| 5. | Lee, S. J., Dimtchev, A., Lavin, M. F., Dritschilo, A., and Jung, M. (1998) Oncogene 17, 1821-1826[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Oleinick, N. L., Balasubramaniam, U., Xue, L., and Chiu, S. (1994) Int. J. Radiat. Biol. 66, 523-529[Medline] [Order article via Infotrieve] |
| 7. | Giles, R. H., Peters, D. J., and Breuning, M. H. (1998) Trends Genet. 14, 178-183[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Wade, P. A., Pruss, D., and Wolffe, A. P. (1997) Trends Biochem. Sci. 22, 128-132[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Grunstein, M. (1997) Nature 389, 349-352[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Bannister, A. J., and Kouzarides, T. (1996) Nature 384, 641-643[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Brehm, A., and Kouzarides, T. (1999) Trends Biochem. Sci. 24, 142-146[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Yarden, R. I.,
and Brody, L. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4983-4988 |
| 13. | Utley, R. T., Ikeda, K., Grant, P. A., Cote, J., Steger, D. J., Eberharter, A., John, S., and Workman, J. L. (1998) Nature 394, 498-502[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Vassilev, A., Yamauchi, J., Kotani, T., Prives, C., Avantaggiati, M. L., Qin, J., and Nakatani, Y. (1998) Mol. Cell 2, 869-876[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Ogryzko, V. V., Kotani, T., Zhang, X., Schiltz, L., Howard, T., Qin, J., and Nakatani, Y. (1998) Cell 94, 35-44[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Siddique, H., Zou, J. P., Rao, V. N., and Reddy, E. S. (1998) Oncogene 16, 2283-2285[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Grant, P. A., Schieltz, D., Pray-Grant, M. G., Yates, J. R., III, and Workman, J. L. (1998) Mol. Cell 2, 863-867[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., and Cole, M. D. (1998) Cell 94, 363-374[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Struhl, K.
(1998)
Genes & Dev.
12,
599-606 |
| 20. |
Wu, C.
(1997)
J. Biol. Chem.
272,
28171-28174 |
| 21. | Pazin, M. J., and Kadonaga, J. T. (1997) Cell 89, 325-328[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Wolffe, A. P. (1997) Nature 387, 16-17[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | DePinho, R. A. (1998) Nature 391, 533-536[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. (1998) Nature 391, 597-601[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998) Nature 391, 601-605[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Ferreira, R.,
Magnaghi-Jaulin, L.,
Robin, P.,
Harel-Bellan, A.,
and Trouche, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10493-10498 |
| 27. | Luo, R. X., Postigo, A. A., and Dean, D. C. (1998) Cell 92, 463-473[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996) Science 272, 408-411[Abstract] |
| 29. |
Carmen, A. A.,
Rundlett, S. E.,
and Grunstein, M.
(1996)
J. Biol. Chem.
271,
15837-15844 |
| 30. | Taunton, J., Hassig, C. A., and Schreiber, S. L. (1996) Science 272, 408-411 |
| 31. |
Guo, C. Y.,
Wang, Y.,
Brautigan, D. L.,
and Larner, J. M.
(1999)
J. Biol. Chem.
274,
18715-18720 |
| 32. |
Gately, D. P.,
Hittle, J. C.,
Chan, G. K. T.,
and Yen, T.
(1998)
Mol. Biol. Cell
9,
2361-2374 |
This article has been cited by other articles:
![]() |
S. A. Rimkus, R. J. Katzenberger, A. T. Trinh, G. E. Dodson, R. S. Tibbetts, and D. A. Wassarman Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia Genes & Dev., May 1, 2008; 22(9): 1205 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Camphausen and P. J. Tofilon Inhibition of Histone Deacetylation: A Strategy for Tumor Radiosensitization J. Clin. Oncol., September 10, 2007; 25(26): 4051 - 4056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Young, J. Jonnalagadda, M. Gatei, D. A. Jans, S. Meyn, and K. K. Khanna Identification of Domains of Ataxia-telangiectasia Mutated Required for Nuclear Localization and Chromatin Association J. Biol. Chem., July 29, 2005; 280(30): 27587 - 27594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gupta, G. G. Sharma, C. S. H. Young, M. Agarwal, E. R. Smith, T. T. Paull, J. C. Lucchesi, K. K. Khanna, T. Ludwig, and T. K. Pandita Involvement of Human MOF in ATM Function Mol. Cell. Biol., June 15, 2005; 25(12): 5292 - 5305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmed, C. Palermo, S. Wan, and N. C. Walworth A Novel Protein with Similarities to Rb Binding Protein 2 Compensates for Loss of Chk1 Function and Affects Histone Modification in Fission Yeast Mol. Cell. Biol., May 1, 2004; 24(9): 3660 - 3669. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses Carcinogenesis, October 1, 2003; 24(10): 1571 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ju and M. T. Muller Histone Deacetylase Inhibitors Activate p21WAF1 Expression via ATM Cancer Res., June 1, 2003; 63(11): 2891 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Anderson and N. D. Perkins The Large Subunit of Replication Factor C Interacts with the Histone Deacetylase, HDAC1 J. Biol. Chem., August 9, 2002; 277(33): 29550 - 29554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. YAN, W. QIANG, N. LIU, J. SHEN, W. S. LYNN, and P. K. Y. WONG The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes FASEB J, May 1, 2001; 15(7): 1132 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Scherthan, M. Jerratsch, S. Dhar, Y. A. Wang, S. P. Goff, and T. K. Pandita Meiotic Telomere Distribution and Sertoli Cell Nuclear Architecture Are Altered in Atm- and Atm-p53-Deficient Mice Mol. Cell. Biol., October 15, 2000; 20(20): 7773 - 7783. [Abstract] [Full Text] |
||||
![]() |
R. L. Cai, Y. Yan-Neale, M. A. Cueto, H. Xu, and D. Cohen HDAC1, a Histone Deacetylase, Forms a Complex with Hus1 and Rad9, Two G2/M Checkpoint Rad Proteins J. Biol. Chem., September 1, 2000; 275(36): 27909 - 27916. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-r. Jeong, D. Wu-Scharf, C. Zhang, and H. Cerutti From the Cover: Suppressors of transcriptional transgenic silencing in Chlamydomonas are sensitive to DNA-damaging agents and reactivate transposable elements PNAS, January 22, 2002; 99(2): 1076 - 1081. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |